AGTC Announces Financial Results for the Quarter Ended September 30, 2015
November 05, 2015 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)...
AGTC Files Investigational New Drug Application for the Treatment of Achromatopsia Caused by Mutations in the CNGB3 Gene
November 02, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 5, 2015
October 27, 2015 16:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC Announces Orphan Drug Designation in the European Union for Gene Therapy to Treat Achromatopsia
October 22, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC Announces Data Evaluating the Natural History of Patients With X-Linked Retinoschisis at the 48th Annual Retina Society Meeting
October 07, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
PARIS, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
AGTC Continues to Expand Management Team With Three Key Hires
October 05, 2015 16:15 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Oct. 5, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical-stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC Announces Publication of Data Supporting Further Investigation of Novel Potential Gene Therapy for Treating X-Linked Retinoschisis (XLRS) in Clinical Studies
September 30, 2015 16:15 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC to Participate in Upcoming Scientific and Investor Conferences
September 21, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...
AGTC Announces Financial Results for the Quarter and Fiscal Year Ended June 30, 2015
September 10, 2015 16:11 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene...
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 10, 2015
September 09, 2015 16:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus...